Since mutant Cysteine residues in the extracellular domain lead to ligand-independent dimerization of FGFR3 on the cell surface [29], we believe this type of SNV may result in the constitutive activation of the receptor in MM, contributing to cell proliferation and survival. The gene discussed is FGFR3; the disease is Miyoshi myopathy.